JUZ-33176-88059 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-26
Dose 1 — Pfizer-BioNTech
2021-01-16
Dose 2 — Pfizer-BioNTech
2021-01-17
Registered in v-safe
2021-01-17
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Joint pains, Fatigue or tiredness

Adult check-in
2021-01-18
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Joint pains, Muscle or body aches

Adult check-in
2021-01-19
Survey response — days 1–6 daily, dose 2
MedDRA: Paraesthesia — Feeling: Good · Site: Pain · Muscle or body aches

Free text: Muscle tingling down arm of injection

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-22
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-30
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-08
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-20
Survey response — day 35, dose 2
MedDRA: Fatigue — Feeling: Fair

Free text: Increased fatigue, cause unknown maybe increased work schedule.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-27
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-17
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-07-17
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-11-08
Dose 3 — Pfizer-BioNTech
2021-11-11
Survey response — days 1–6 daily, dose 3
MedDRA: Heavy menstrual bleeding — Feeling: Poor · Site: Pain, Swelling · Fever · Headache

Free text: Additional menstrual bleeding

MedDRA releases: 2024-11 · check-in free text available
2021-11-17
Health check-in — day 7, dose 3
Feeling: Fair · Headache

Adult check-in
2021-11-22
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2022-02-07
Health check-in — 3 months, dose 3
Feeling: Good

Adult check-in
2022-05-11
Survey response — 6 months, dose 3
MedDRA: Habitual abortion — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Recurrent pregnancy loss

MedDRA releases: 2024-11 · check-in free text available
2022-05-11
Report sent to call center — 6 months, dose 3
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-05-12
Call 1 — Left Voicemail
2022-11-08
Health check-in — 12 months, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-26	Pfizer-BioNTech
2	2021-01-16	Pfizer-BioNTech
3	2021-11-08	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2022-05-11	Unsuccessful

Free text

Release 2 — days 1–6 daily, dose 2

2021-01-19

Systemic reaction (other): Muscle tingling down arm of injection

Release 4 — day 35, dose 2

2021-02-20

Symptoms: Increased fatigue, cause unknown maybe increased work schedule.

Release 10 — days 1–6 daily, dose 3

2021-11-11

Systemic reaction (other): Additional menstrual bleeding

Release 11 — 6 months, dose 3

2022-05-11

Symptoms: Recurrent pregnancy loss

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Fatigue	✓	✓	✓
SD	Habitual abortion	·	·	✓
SRO	Heavy menstrual bleeding	·	·	✓
SRO	Paraesthesia	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release